Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 24;10(6):664.
doi: 10.3390/nu10060664.

Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children

Affiliations
Review

Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children

Lorenzo Norsa et al. Nutrients. .

Abstract

Intestinal failure-associated liver disease (IFALD) is a threatening complication for children on long-term parenteral nutrition because of intestinal failure. When progressive and intractable, it may jeopardize intestinal rehabilitation and lead to combined liver and intestinal transplantation. The institution of dedicated intestinal failure centers has dramatically decreased the incidence of such complication. IFALD may rapidly fade away if very early management aimed at preventing progression to end-stage liver disease is provided. In this review, we address the etiology and risk factors of IFALD in order to introduce pillars of prevention (nutritional management and catheter-related infections control). The latest evidence of therapeutic strategies, such as medical and surgical treatments, is also discussed.

Keywords: children; intestinal failure; liver disease; parenteral nutrition; prevention; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Factors affecting intestinal failure-associated liver disease. PN: parenteral nutrition, NEC: necrotizing enterocololitis.
Figure 2
Figure 2
Suggestion of long-term parenteral nutrition preparation for children above 6 months of age. FO: fish oil, LE: lipid emulsion, PN: parenteral nutrition.

Similar articles

Cited by

References

    1. Goulet O., Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology. 2006;130:S16–S28. doi: 10.1053/j.gastro.2005.12.002. - DOI - PubMed
    1. Wessel J.J., Kocoshis S.A. Nutritional management of infants with short bowel syndrome. Semin. Perinatol. 2007;31:104–111. doi: 10.1053/j.semperi.2007.02.009. - DOI - PubMed
    1. Goulet O., Joly F., Corriol O., Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr. Opin. Organ Transplant. 2009;14:256–261. doi: 10.1097/MOT.0b013e32832ac06f. - DOI - PubMed
    1. Lacaille F., Gupte G., Colomb V., D’Antiga L., Hartman C., Hojsak I., Kolacek S., Puntis J., Shamir R., ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation Intestinal failure-associated liver disease: A position paper of the ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation. J. Pediatr. Gastroenterol. Nutr. 2015;60:272–283. doi: 10.1097/MPG.0000000000000586. - DOI - PubMed
    1. Tufano M., Nicastro E., Giliberti P., Vegnente A., Raimondi F., Iorio R. Cholestasis in neonatal intensive care unit: Incidence, aetiology and management. Acta Paediatr. Oslo Nor. 1992. 2009;98:1756–1761. doi: 10.1111/j.1651-2227.2009.01464.x. - DOI - PubMed

LinkOut - more resources